Detalhe da pesquisa
1.
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Cancer Immunol Immunother
; 72(8): 2649-2657, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067554
2.
Evaluation of a self-questionnaire to screen for neurological complications associated with immunological checkpoint inhibitors: Are we missing something?
Rev Neurol (Paris)
; 179(10): 1095-1102, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714728
3.
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Ann Oncol
; 33(2): 204-215, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710571
4.
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.
Ann Oncol
; 32(10): 1276-1285, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293460
5.
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort dataâ.
Ann Oncol
; 32(4): 542-551, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385520
6.
Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Br J Dermatol
; 184(6): 1059-1067, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131055
7.
[Mohs micrographic surgery for skin cancers: A 10 year - single-center series of 548 patients treated by formalin-fixed tissue Mohs surgery assessing the impact of reduced margins]. / Prise en charge des tumeurs cutanées selon la technique Slow Mohs « en gâteau ¼ : étude rétrospective monocentrique sur 10 ans de 548 patients évaluant l'impact de la diminution des marges.
Ann Chir Plast Esthet
; 66(6): 429-439, 2021 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-34330553
8.
The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Br J Dermatol
; 182(1): 76-84, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021404
9.
[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices]. / Mélanome au stade ganglionnaire : analyse du ganglion sentinelle, curage ganglionnaire, perspective des traitements adjuvants. Enquête nationale française sur les pratiques actuelles et envisagées.
Ann Dermatol Venereol
; 147(1): 9-17, 2020 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-31761496
10.
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.
Br J Dermatol
; 180(4): 765-773, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367470
11.
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
J Eur Acad Dermatol Venereol
; 38(1): e71-e73, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595320
12.
[Primitive myxoid melanoma: An unusual histological aspect]. / Mélanome myxoïde primitif : une forme histologique inhabituelle.
Ann Dermatol Venereol
; 146(5): 372-376, 2019 May.
Artigo
em Francês
| MEDLINE | ID: mdl-30910333
13.
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]. / Développement, mise en Åuvre et objectifs de CARADERM, réseau national cancers cutanés rares partie carcinomes annexiels.
Ann Dermatol Venereol
; 146(11): 704-710, 2019 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-31582261
14.
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
Ann Dermatol Venereol
; 151(1): 103243, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325268
15.
Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].
Ann Oncol
; 33(8): 853, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690517
16.
Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors.
Br J Dermatol
; 186(3): 579-581, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817864
17.
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.
Br J Cancer
; 114(11): 1199-205, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140316
18.
Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma.
Br J Dermatol
; 173(4): 1059-62, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25998864
19.
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group.
Br J Dermatol
; 173(4): 1015-23, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149621
20.
Systematic skin examination in an acute geriatric unit: skin cancer prevalence.
Clin Exp Dermatol
; 40(4): 356-60, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623526